Envisioning a transformed clinical trials enterprise in the United States : establishing an agenda for 2020: workshop summary /

Envisioning a transformed clinical trials enterprise in the United States : establishing an agenda for 2020: workshop summary / / Neil Weisfeld, Rebecca A. English, and Anne B. Claiborne, rapporteurs; Forum on Drug Discovery, Development, and Translation; Board on Health Sciences Policy.

Saved in:
Bibliographic Details
:
Institute of Medicine (U.S.). Forum on Drug Discovery, Development, and Translation.
TeilnehmendeR:
Weisfeld, Neil E.
English, Rebecca A.
Claiborne, Anne B.
Institute of Medicine (U.S.). Forum on Drug Discovery, Development, and Translation.
Institute of Medicine (U.S.). Board on Health Sciences Policy.
National Academies Press (U.S.)
ProQuest (Firm)
Year of Publication:2012
Language:English
Online Access:
Physical Description:xvi, 232 p. :; ill.
Tags: Add Tag
No Tags, Be the first to tag this record!
id 5003379028
ctrlnum (MiAaPQ)5003379028
(Au-PeEL)EBL3379028
(CaPaEBR)ebr10606369
(CaONFJC)MIL394882
(OCoLC)902942425
collection bib_alma
fullrecord <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01768nam a2200397Ia 4500</leader><controlfield tag="001">5003379028</controlfield><controlfield tag="003">MiAaPQ</controlfield><controlfield tag="005">20200520144314.0</controlfield><controlfield tag="006">m o d | </controlfield><controlfield tag="007">cr cn|||||||||</controlfield><controlfield tag="008">111220s2012 dcua sb 000 0 eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="z">9780309253154</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="z">0309253152</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(MiAaPQ)5003379028</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(Au-PeEL)EBL3379028</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(CaPaEBR)ebr10606369</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(CaONFJC)MIL394882</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)902942425</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">MiAaPQ</subfield><subfield code="c">MiAaPQ</subfield><subfield code="d">MiAaPQ</subfield></datafield><datafield tag="050" ind1=" " ind2="4"><subfield code="a">R853.C55</subfield><subfield code="b">E585 2012</subfield></datafield><datafield tag="245" ind1="0" ind2="0"><subfield code="a">Envisioning a transformed clinical trials enterprise in the United States</subfield><subfield code="h">[electronic resource] :</subfield><subfield code="b">establishing an agenda for 2020: workshop summary /</subfield><subfield code="c">Neil Weisfeld, Rebecca A. English, and Anne B. Claiborne, rapporteurs; Forum on Drug Discovery, Development, and Translation; Board on Health Sciences Policy.</subfield></datafield><datafield tag="260" ind1=" " ind2=" "><subfield code="a">Washington :</subfield><subfield code="b">National Academies Press,</subfield><subfield code="c">2012.</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">xvi, 232 p. :</subfield><subfield code="b">ill.</subfield></datafield><datafield tag="504" ind1=" " ind2=" "><subfield code="a">Includes bibliographical references.</subfield></datafield><datafield tag="533" ind1=" " ind2=" "><subfield code="a">Electronic reproduction. Ann Arbor, MI : ProQuest, 2015. Available via World Wide Web. Access may be limited to ProQuest affiliated libraries.</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Clinical trials</subfield><subfield code="z">United States.</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Clinical medicine</subfield><subfield code="x">Research</subfield><subfield code="z">United States.</subfield></datafield><datafield tag="655" ind1=" " ind2="4"><subfield code="a">Electronic books.</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Weisfeld, Neil E.</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">English, Rebecca A.</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Claiborne, Anne B.</subfield></datafield><datafield tag="710" ind1="2" ind2=" "><subfield code="a">Institute of Medicine (U.S.).</subfield><subfield code="b">Forum on Drug Discovery, Development, and Translation.</subfield></datafield><datafield tag="710" ind1="2" ind2=" "><subfield code="a">Institute of Medicine (U.S.).</subfield><subfield code="b">Board on Health Sciences Policy.</subfield></datafield><datafield tag="710" ind1="2" ind2=" "><subfield code="a">National Academies Press (U.S.)</subfield></datafield><datafield tag="710" ind1="2" ind2=" "><subfield code="a">ProQuest (Firm)</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://ebookcentral.proquest.com/lib/oeawat/detail.action?docID=3379028</subfield><subfield code="z">Click to View</subfield></datafield></record></collection>
record_format marc
spelling Envisioning a transformed clinical trials enterprise in the United States [electronic resource] : establishing an agenda for 2020: workshop summary / Neil Weisfeld, Rebecca A. English, and Anne B. Claiborne, rapporteurs; Forum on Drug Discovery, Development, and Translation; Board on Health Sciences Policy.
Washington : National Academies Press, 2012.
xvi, 232 p. : ill.
Includes bibliographical references.
Electronic reproduction. Ann Arbor, MI : ProQuest, 2015. Available via World Wide Web. Access may be limited to ProQuest affiliated libraries.
Clinical trials United States.
Clinical medicine Research United States.
Electronic books.
Weisfeld, Neil E.
English, Rebecca A.
Claiborne, Anne B.
Institute of Medicine (U.S.). Forum on Drug Discovery, Development, and Translation.
Institute of Medicine (U.S.). Board on Health Sciences Policy.
National Academies Press (U.S.)
ProQuest (Firm)
https://ebookcentral.proquest.com/lib/oeawat/detail.action?docID=3379028 Click to View
language English
format Electronic
eBook
author2 Weisfeld, Neil E.
English, Rebecca A.
Claiborne, Anne B.
Institute of Medicine (U.S.). Forum on Drug Discovery, Development, and Translation.
Institute of Medicine (U.S.). Board on Health Sciences Policy.
National Academies Press (U.S.)
ProQuest (Firm)
author_facet Weisfeld, Neil E.
English, Rebecca A.
Claiborne, Anne B.
Institute of Medicine (U.S.). Forum on Drug Discovery, Development, and Translation.
Institute of Medicine (U.S.). Board on Health Sciences Policy.
National Academies Press (U.S.)
ProQuest (Firm)
Institute of Medicine (U.S.). Forum on Drug Discovery, Development, and Translation.
Institute of Medicine (U.S.). Board on Health Sciences Policy.
National Academies Press (U.S.)
ProQuest (Firm)
author2_variant n e w ne new
r a e ra rae
a b c ab abc
author2_role TeilnehmendeR
TeilnehmendeR
TeilnehmendeR
TeilnehmendeR
TeilnehmendeR
TeilnehmendeR
TeilnehmendeR
author_corporate Institute of Medicine (U.S.). Forum on Drug Discovery, Development, and Translation.
Institute of Medicine (U.S.). Board on Health Sciences Policy.
National Academies Press (U.S.)
ProQuest (Firm)
author_sort Weisfeld, Neil E.
title Envisioning a transformed clinical trials enterprise in the United States establishing an agenda for 2020: workshop summary /
spellingShingle Envisioning a transformed clinical trials enterprise in the United States establishing an agenda for 2020: workshop summary /
title_sub establishing an agenda for 2020: workshop summary /
title_full Envisioning a transformed clinical trials enterprise in the United States [electronic resource] : establishing an agenda for 2020: workshop summary / Neil Weisfeld, Rebecca A. English, and Anne B. Claiborne, rapporteurs; Forum on Drug Discovery, Development, and Translation; Board on Health Sciences Policy.
title_fullStr Envisioning a transformed clinical trials enterprise in the United States [electronic resource] : establishing an agenda for 2020: workshop summary / Neil Weisfeld, Rebecca A. English, and Anne B. Claiborne, rapporteurs; Forum on Drug Discovery, Development, and Translation; Board on Health Sciences Policy.
title_full_unstemmed Envisioning a transformed clinical trials enterprise in the United States [electronic resource] : establishing an agenda for 2020: workshop summary / Neil Weisfeld, Rebecca A. English, and Anne B. Claiborne, rapporteurs; Forum on Drug Discovery, Development, and Translation; Board on Health Sciences Policy.
title_auth Envisioning a transformed clinical trials enterprise in the United States establishing an agenda for 2020: workshop summary /
title_new Envisioning a transformed clinical trials enterprise in the United States
title_sort envisioning a transformed clinical trials enterprise in the united states establishing an agenda for 2020: workshop summary /
publisher National Academies Press,
publishDate 2012
physical xvi, 232 p. : ill.
callnumber-first R - Medicine
callnumber-subject R - General Medicine
callnumber-label R853
callnumber-sort R 3853 C55 E585 42012
genre Electronic books.
genre_facet Electronic books.
geographic_facet United States.
url https://ebookcentral.proquest.com/lib/oeawat/detail.action?docID=3379028
illustrated Illustrated
oclc_num 902942425
work_keys_str_mv AT weisfeldneile envisioningatransformedclinicaltrialsenterpriseintheunitedstatesestablishinganagendafor2020workshopsummary
AT englishrebeccaa envisioningatransformedclinicaltrialsenterpriseintheunitedstatesestablishinganagendafor2020workshopsummary
AT claiborneanneb envisioningatransformedclinicaltrialsenterpriseintheunitedstatesestablishinganagendafor2020workshopsummary
AT instituteofmedicineusforumondrugdiscoverydevelopmentandtranslation envisioningatransformedclinicaltrialsenterpriseintheunitedstatesestablishinganagendafor2020workshopsummary
AT instituteofmedicineusboardonhealthsciencespolicy envisioningatransformedclinicaltrialsenterpriseintheunitedstatesestablishinganagendafor2020workshopsummary
AT nationalacademiespressus envisioningatransformedclinicaltrialsenterpriseintheunitedstatesestablishinganagendafor2020workshopsummary
AT proquestfirm envisioningatransformedclinicaltrialsenterpriseintheunitedstatesestablishinganagendafor2020workshopsummary
status_str n
ids_txt_mv (MiAaPQ)5003379028
(Au-PeEL)EBL3379028
(CaPaEBR)ebr10606369
(CaONFJC)MIL394882
(OCoLC)902942425
is_hierarchy_title Envisioning a transformed clinical trials enterprise in the United States establishing an agenda for 2020: workshop summary /
author2_original_writing_str_mv noLinkedField
noLinkedField
noLinkedField
noLinkedField
noLinkedField
noLinkedField
noLinkedField
_version_ 1792330867192889344

Similar Items